PROCEPT BioRobotics (PRCT) Other Accumulated Expenses (2020 - 2026)

PROCEPT BioRobotics (PRCT) has reported Other Accumulated Expenses for 7 consecutive years, with $12.1 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Other Accumulated Expenses rose 24.73% year-over-year to $12.1 million in Q2 2026; TTM through Jun 2026 was $12.1 million, a 24.73% increase from a year earlier, with the FY2025 full-year figure at $10.1 million, up 24.53% from the prior year.
• Other Accumulated Expenses was $12.1 million for Q2 2026 at PROCEPT BioRobotics, up from $10.2 million in the prior quarter.
• Over five years, Other Accumulated Expenses peaked at $12.1 million in Q2 2026 and troughed at $4.0 million in Q1 2022.
• A 5-year average of $7.9 million and a median of $7.9 million in 2023 frame the typical range for Other Accumulated Expenses.
• Across the five-year window, Other Accumulated Expenses soared 109.21% in 2022 and retreated 15.4% in 2023, its largest moves.
• Over 5 years, Other Accumulated Expenses stood at $7.5 million in 2022, then dropped by 15.4% to $6.3 million in 2023, then gained by 28.03% to $8.1 million in 2024, then advanced by 24.53% to $10.1 million in 2025, then advanced by 20.03% to $12.1 million in 2026.
• The last three Other Accumulated Expenses figures came in at $12.1 million (Q2 2026), $10.2 million (Q1 2026), and $10.1 million (Q4 2025), per Business Quant data.